LobbyingPartnership for Quality Home Healthcare lobbying by quarter
Partnership for Quality Home Healthcare's latest lobbying report covers Q1 2025, at $250K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Partnership for Quality Home Healthcare
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $660K | 5 |
| Q1 2023 | $640K | 5 |
| Q2 2023 | $660K | 5 |
| Q3 2023 | $660K | 5 |
| Q4 2023 | $660K | 5 |
| Q1 2024 | $550K | 5 |
| Q2 2024 | $450K | 5 |
| Q3 2024 | $460K | 5 |
| Q4 2024 | $460K | 5 |
| Q1 2025 | $250K | 3 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2.8M · 37 reports
- Medicare and Medicaid$2.4M · 31 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)30 reports
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
- Centers For Medicare and Medicaid Services (CMS)29 reports
- Office of Management & Budget (OMB)6 reports
- Executive Office of the President (EOP)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-housePartnership for Quality Home Healthcare | $3.7M | 10 quarters |
| Liberty Partners Group | $720K | 10 quarters |
| Alston & Bird | $450K | 9 quarters |
| Dentons US | $430K | 10 quarters |
| Tauzin Strategic Networks | $180K | 7 quarters |
| Federal Health Policy Strategies | $20K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| W.J. TAUZIN | Member of Congress (LA-3) | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/04/21for Q1 2025 | Liberty Partners Group | $80K |
| 25/04/14for Q1 2025 | Dentons US | Under $5,000 |
| 25/04/09for Q1 2025 | In-house | $170K |
| 25/01/21for Q4 2024 | In-house | $330K |
| 25/01/21for Q4 2024 | Federal Health Policy Strategies | $10K |
| 25/01/21for Q4 2024 | Alston & Bird | $50K |
| 25/01/20for Q4 2024 | Liberty Partners Group | $70K |
| 25/01/10for Q4 2024 | Dentons US | Under $5,000 |
| 24/10/21for Q3 2024 | Alston & Bird | $50K |
| 24/10/21for Q3 2024 | Federal Health Policy Strategies | $10K |
| 24/10/19for Q3 2024 | Liberty Partners Group | $70K |
| 24/10/17for Q3 2024 | Dentons US | Under $5,000 |
| 24/10/10for Q3 2024 | In-house | $330K |
| 24/10/10for Q3 2024 | Federal Health Policy Strategies | Under $5,000 |
| 24/07/22for Q2 2024 | Alston & Bird | $50K |
| 24/07/21for Q2 2024 | In-house | $330K |
| 24/07/19for Q2 2024 | Liberty Partners Group | $70K |
| 24/07/08for Q2 2024 | Dentons US | Under $5,000 |
| 24/07/03for Q2 2024 | Tauzin Strategic Networks | Under $5,000 |
| 24/04/22for Q1 2024 | Alston & Bird | $50K |